Northfield Laboratories Presentation at the BIO CEO & Investor Conference to be Webcast Live
February 08 2006 - 7:00AM
PR Newswire (US)
EVANSTON, Ill., Feb. 8 /PRNewswire-FirstCall/ -- Northfield
Laboratories Inc. (NASDAQ:NFLD) announced today that Steven A.
Gould, M.D., Chairman and Chief Executive Officer, will be
presenting at the BIO CEO & Investor Conference on February 15,
2006 at 1:15 p.m. E.T. Interested investors may access the live
webcast of the presentation at http://www.northfieldlabs.com/. A
replay of the presentation will be available and will be archived
for two weeks. About Northfield Laboratories Northfield
Laboratories Inc. is a leader in developing an oxygen-carrying
resuscitative fluid, PolyHeme(R), for the treatment of urgent,
large volume blood loss in trauma and resultant surgical settings.
PolyHeme(R) is a solution of chemically modified human hemoglobin
that requires no cross matching and is therefore compatible with
all blood types. It has a shelf life in excess of 12 months.
Enrollment is currently underway in a pivotal Phase III trial of
PolyHeme(R) beginning in the pre-hospital setting. For further
information, visit http://www.northfieldlabs.com/. FOR FURTHER
INFORMATION CONTACT: Sophia H. Twaddell Vice President, Corporate
Communications (847) 864-3500 Sharon L. Weinstein Director,
Investor Relations Noonan Russo (212) 845-4271 First Call Analyst:
FCMN Contact: Sharon.Weinstein@eurorscg.com DATASOURCE: Northfield
Laboratories Inc. CONTACT: Sophia H. Twaddell, Vice President,
Corporate Communications of Northfield Laboratories Inc.,
+1-847-864-3500, ; Sharon L. Weinstein, Director, Investor
Relations, Noonan Russo, +1-212-845-4271, , for Northfield
Laboratories Inc. Web site: http://www.northfieldlabs.com/
Copyright
Northfield labs (NASDAQ:NFLD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Northfield labs (NASDAQ:NFLD)
Historical Stock Chart
From Jul 2023 to Jul 2024